Tempus AI, Inc. $TEM Shares Bought by Trivium Point Advisory LLC

Key Points

• Trivium Point Advisory LLC significantly increased its stake in Tempus AI, Inc. by 670.7% during Q2, owning 38,627 shares worth approximately $2.45 million.
• Research analysts are optimistic about Tempus AI, with several firms raising their target prices, including HC Wainwright, which increased its price target from $90 to $98 and maintained a "buy" rating.
• Insider selling was reported, with CFO James Rogers selling over 7,500 shares, resulting in a 5.16% decrease in ownership, while corporate insiders collectively own 26.27% of the company's stock.

Trivium Point Advisory LLC boosted its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 670.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 38,627 shares of the company's stock after purchasing an additional 33,615 shares during the period. Trivium Point Advisory LLC's holdings in Tempus AI were worth $2,454,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cherry Tree Wealth Management LLC acquired a new position in Tempus AI during the first quarter valued at $31,000. University of Texas Texas AM Investment Management Co. acquired a new position in Tempus AI during the first quarter valued at $33,000. Continuum Advisory LLC acquired a new position in Tempus AI during the first quarter valued at $39,000. Bartlett & CO. Wealth Management LLC lifted its position in Tempus AI by 100.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock valued at $39,000 after purchasing an additional 400 shares during the period. Finally, Nemes Rush Group LLC acquired a new position in Tempus AI during the first quarter valued at $39,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on TEM shares. HC Wainwright boosted their target price on shares of Tempus AI from $90.00 to $98.00 and gave the company a "buy" rating in a research report on Friday, September 12th. Needham & Company LLC reiterated a "buy" rating and issued a $70.00 price objective on shares of Tempus AI in a research report on Friday, August 8th. Morgan Stanley upped their price objective on shares of Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 12th. Guggenheim upped their price objective on shares of Tempus AI from $80.00 to $95.00 and gave the stock a "buy" rating in a research report on Friday. Finally, Bank of America upped their price objective on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 25th. Seven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to data from MarketBeat, Tempus AI presently has a consensus rating of "Moderate Buy" and a consensus target price of $71.83.

Insider Buying and Selling at Tempus AI

In other news, CFO James William Rogers sold 7,528 shares of the business's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $561,965.20. Following the completion of the sale, the chief financial officer owned 138,473 shares of the company's stock, valued at $10,337,009.45. The trade was a 5.16% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Erik Phelps sold 3,664 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $273,517.60. Following the transaction, the executive vice president owned 94,115 shares in the company, valued at $7,025,684.75. The trade was a 3.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 933,662 shares of company stock valued at $67,909,393. Corporate insiders own 26.27% of the company's stock.

Tempus AI Stock Up 0.1%

TEM stock opened at $78.57 on Tuesday. The stock has a market capitalization of $13.65 billion, a P/E ratio of -66.03 and a beta of 5.08. The firm has a 50-day simple moving average of $73.06 and a 200-day simple moving average of $62.29. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. Tempus AI, Inc. has a 52 week low of $31.36 and a 52 week high of $97.79.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, topping analysts' consensus estimates of ($0.23) by $0.01. The business had revenue of $314.64 million during the quarter, compared to analysts' expectations of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company's quarterly revenue was up 89.5% on a year-over-year basis. During the same quarter in the previous year, the company earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Tempus AI Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.